ArticleTranslational cancer research2025
Neutrophil-to-lymphocyte ratio as a prognostic predictor in adrenocortical carcinoma: a retrospective cohort study stratified by cortisol secretion status.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adrenocortical carcinoma (ACC), an extremely uncommon and highly aggressive endocrine malignancy, has few therapeutic options and is associated with a poor prognosis. This study aimed to evaluate the prognostic significance of preoperative neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in a Chinese cohort with ACC and to determine the influence of cortisol secretion on these inflammatory markers. Methods: We retrospectively analyzed 45 patients with ACC treated at a single institution from 1985 to 2020. Baseline clinicopathological data, preoperative NLR and PLR values, and follow-up information were collected. The NLR cutoff of 3.9 was selected a priori based on previously published studies of ACC. Disease-specific survival (DSS) was assessed via Kaplan-Meier and Cox proportional hazards models. Patients were stratified according to the presence of Cushing's syndrome (CS) in order to specifically assess the influence of hypercortisolemia. Results: A total of 33 disease-specific deaths occurred during the follow-up period. Multivariate analysis indicated that the independent predictors of worse DSS were NLR >3.9 [hazard ratio (HR) =4.12, 95% confidence interval (CI): 1.25-13.61, P=0.02], an elevated Ki-67 index (HR =1.04, 95% CI: 1.01-1.07, P=0.01), and advanced European Network for the Study of Adrenal Tumors (ENSAT) stage (III-IV) (HR =45.64, 95% CI: 2.88-724.60, P=0.007). Although NLR was significantly higher in patients with CS than without CS (5.07 Conclusions: Preoperative NLR >3.9 may serve as a simple and accessible prognostic marker for DSS in Chinese patients with ACC. Its predictive value is influenced by both tumor-induced inflammation and cortisol secretion, highlighting its utility in risk stratification beyond traditional factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.